Seleziona una pagina

TEAM

We develop and make available new compounds for the treatment of viral infections, which are innovative in terms of approach

Santo Landolfo, MD, PhD

Santo Landolfo, MD, PhD

R&D supervisor, Responsible for communication

santo.landolfo@ntovir.it

Curriculum Vitae

He is Full Professor of Microbiology and Clinical Microbiology at the University of Turin, School of Medicine. He has been Director of the Immunogenetics and Experimental Oncology Center, National Research Council, Turin. He has published over 260 scientific papers in the areas of Interferons, Viral Infections and Autoimmunity. In 2003 he has been awarded by the Italian National Academy of Sciences, Rome, Italy, for the studies on the role of Interferon inducible genes in the resistance against Cytomegalovirus Infections. He is a Fellow of the American Society of Microbiology, European Society of Virology, International Cytokine and Interferon Society, and Italian Society of Microbiology. He has been founder and owner of the academic spin-off Notopharm Srl, and involved in the startup phase of two other academic spin-offs. He is inventor of more than 10 international patents. He regularly serves on grant review boards and advisory panels at Italian Minister for University and Research.

Tommaso Lupo Landolfo, MD

Tommaso Lupo Landolfo, MD

CEO, Responsible for clinical development, Legal Representative

tommaso.landolfo@notovir.it

Curriculum Vitae

He is a Medical Oncology Resident and PhD student at the University of Eastern Piedmont and the Maggiore della CaritĂ  Hospital in Novara, Italy. He earned his Medical degree in 2024 from the University of Turin. Currently, he is specializing in Medical Oncology, focusing on advanced clinical and therapeutic strategies for cancer treatment, and pursuing a PhD in Food Health and Longevity.

He is dedicated to exploring the connections between nutrition, health, and disease prevention, aiming to develop innovative approaches to oncology and patient care. His research interests include the impact of diet and lifestyle on cancer prevention and treatment outcomes.

Marco De Andrea, MD, PhD

Marco De Andrea, MD, PhD

CTO, Laboratory coordinator, Responsible for biomaterials

marco.deandrea@notovir.it

Curriculum Vitae

He is Associate Professor of Microbiology and Clinical Microbiology at the University of Turin, School of Medicine. He received his degree in Biology in 1996 from the University of Turin – Italy, where he also completed his PhD program in Immunology. He received his Medical degree in 2008 from the University of Piemonte Orientale, Novara – Italy. He is member of the European Society of Virology, International Cytokine and Interferon Society, European Crohn’s and Colitis European Organisation – ECCO, and Italian Society of Microbiology. His research interests are on the role of Interferon inducible genes in the resistance against Cytomegalovirus Infections, on intrinsic immunity to viral and bacterial infections, and on the role of AIM2-like sensors in the pathogenesis of autoimmune diseases. He is an active member of the Translational Center for Autoimmune and Allergic Disease – CAAD at University of Piemonte Orientale, Novara – Italy. He is author of more than 70 scientific papers on international peer-reviewed journals, with topics related to viral infections and autoimmunity. He is inventor of two international patents.

Bianca Brugo

Bianca Brugo

Biotechnology Data Analyst, R&D Department Assistant

bianca.brugo@notovir.it

Marisa Gariglio, MD, PhD

Marisa Gariglio, MD, PhD

Scientific Advisor, Univ. Eastern Piedmont - Novara

marisa.gariglio@uniupo.it

Valentina Dell'Oste, PhD.

Valentina Dell'Oste, PhD.

Scientific Advisor, Univ. Turin

valentina.delloste@unito.it

NoToVir Srl

Operating location: Department of Translational Medicine – Via Solaroli 17, 28100 Novara, Italy

Registered office: C.so della Vittoria 20, 28100 Novara, Italy

VAT Number: 02543980037

info@notovir.it

Informativa cookies

3 + 4 =